Format

Send to

Choose Destination
See comment in PubMed Commons below
J Med Life. 2013 Jun 15;6(2):161-7. Epub 2013 Jun 25.

Alcoholic hepatitis.

Author information

1
Centro Alcologico Regionale - Regione Liguria, Alcohol Unit, Department of Internal and Specialist Medicine, IRCCS AOU San Martino-National Institute for Cancer research, Genova, Italy. gianni.testino@hsanmartino.it

Abstract

Alcoholic hepatitis (AH) is a clinical syndrome characterized by jaundice and liver failure that generally occurs after decades of harmful alcohol consumption. Less severe forms of acute AH (AAH) frequently respond to alcoholic abstinence; whereas severe AAHs are characterized by a poor prognosis: up to 40-60% of these patients die within six months. Glucocorticoids currently remain the mainstay for treating severe AAH in patients with Maddrey's Discriminant Function score > 32. Standard contraindications include recent upper gastrointestinal bleeding, renal insufficiency and uncontrolled infections. The evaluation of concomitant viral infections (hepatitis C and B viruses) is mandatory. Liver transplantation (LT), in non-responders patients, is a possible therapeutic option for severe AAH, but it is rarely used because a 6-month abstinence period is required before listing for LT. Unfortunately, most of these patients die before the end of this sober period. In our opinion, in case of severe AAH and in case of patients with a good social support and without severe psychotic or personality disorders, the lack of pre-LT abstinence period alone should not be considered a hindrance to LT.

KEYWORDS:

Alcoholic Hepatitis; Alcoholic Liver Disease; Liver Transplantation

PMID:
23904876
PMCID:
PMC3725441
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center